Antiretroviral Drug Repositioning for Glioblastoma is a research paper published in Cancers (2024). On theSindex it has a DataRank of 0.281. It has been cited 5 times, with 3 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0.0121
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 3 citers.
Dwoskin Family Fund
Grant: N/A
NREF
Grant: NREF-2022-01
Florida Center for Brain Tumor Research
Grant: FCBTR-2022-01
NIGMS NIH HHS
Grant: T32 GM145462
NIH NCI K12 Calabresi Award
Grant: 2K12CA226330-06
UM Calabresi Clinical Oncology Research Career Development Award
UM American Cancer Society Intramural Funding
Grant: ACSP-2023-01
NCI NIH HHS
Grant: K12 CA226330
FWCI
1.39
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals